Suppr超能文献

伽玛刀放射外科治疗库欣病和尼尔森综合征。

Gamma knife radiosurgery for Cushing's disease and Nelson's syndrome.

作者信息

Marek Josef, Ježková Jana, Hána Václav, Kršek Michal, Liščák Roman, Vladyka Vilibald, Pecen Ladislav

机构信息

Third Department of Medicine, First Medical Faculty, Charles University, U nemocnice 1, 128 02, Prague 2, Czech Republic.

出版信息

Pituitary. 2015 Jun;18(3):376-84. doi: 10.1007/s11102-014-0584-7.

Abstract

PURPOSE

This paper presents our 18 years of experience in treating ACTH secreting adenomas (Cushing's disease and Nelson's syndrome) using the Leksell gamma knife (LGK) irradiation.

METHODS

Twenty-six patients with Cushing's disease were followed-up after LGK irradiation for 48-216 months (median 78 months). Seventeen patients had undergone previous surgery, in nine patients LGK irradiation was the primary therapy. Furthermore, 14 patients with Nelson's syndrome were followed-up for 30-204 months (median 144 months).

RESULTS

LGK treatment resulted in hormonal normalization in 80.7 % of patients with Cushing's disease. Time to normalization was 6-54 months (median 30 months). The volume of the adenoma decreased in 92.3% (in 30.7% disappeared completely). There was no recurrence of the disease. In all 14 patients with Nelson's syndrome ACTH levels decreased (in two patients fully normalized) their ACTH levels. When checked up 5-10 years after irradiation regrowth of the adenoma was only detected in one patient (9.1%), in 27.3% adenoma volume remained unchanged, in 45.4% adenoma volume decreased and in 18.2% adenoma completely disappeared. Hypopituitarism did not develop in any patient where the critical dose to the pituitary and distal infundibulum was respected.

CONCLUSION

LGK radiation represents an effective and well-tolerated option for the treatment of patients with Cushing's disease after unsuccessful surgery and may be valuable even as a primary treatment in patients who are not suitable for, or refuse, surgery. In the case of Nelson's syndrome it is possible to impede tumorous growth and control the size of the adenoma in almost all patients.

摘要

目的

本文介绍了我们使用Leksell伽玛刀(LGK)照射治疗促肾上腺皮质激素(ACTH)分泌性腺瘤(库欣病和纳尔逊综合征)18年的经验。

方法

26例库欣病患者在LGK照射后进行了48 - 216个月(中位时间78个月)的随访。17例患者曾接受过手术,9例患者LGK照射是主要治疗方法。此外,14例纳尔逊综合征患者进行了30 - 204个月(中位时间144个月)的随访。

结果

LGK治疗使80.7%的库欣病患者激素水平恢复正常。恢复正常的时间为6 - 54个月(中位时间30个月)。腺瘤体积缩小的患者占92.3%(30.7%完全消失)。疾病无复发。所有14例纳尔逊综合征患者的ACTH水平均下降(2例患者完全恢复正常)。照射后5 - 10年检查时,仅1例患者(9.1%)发现腺瘤再生长,27.3%的患者腺瘤体积保持不变,45.4%的患者腺瘤体积缩小,18.2%的患者腺瘤完全消失。在任何尊重垂体和远端漏斗部临界剂量的患者中均未发生垂体功能减退。

结论

LGK放射治疗是手术失败后库欣病患者的一种有效且耐受性良好的治疗选择,对于不适合或拒绝手术的患者,即使作为主要治疗方法也可能有价值。对于纳尔逊综合征,几乎所有患者都有可能抑制肿瘤生长并控制腺瘤大小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验